Nanoparticles for cancer gene therapy: Recent advances, challenges, and strategies

Area of Science:

• Oncology and Gene Therapy
• Nanotechnology in Medicine

Background:

• Conventional cancer treatments have limitations in potency, specificity, and toxicity.
• Gene therapy presents a promising alternative with advantages like high specificity and reduced side effects.
• Nanoparticles are emerging as efficient and versatile gene delivery systems for cancer treatment.

Purpose of the Study:

• To provide an overview of gene therapeutics and delivery technologies for cancer treatment.
• To highlight recent advancements in nanoparticle-based gene therapy for cancer.
• To discuss the challenges and future insights into designing nanoparticles for cancer gene therapy.

Main Methods:

• Review of current literature on gene therapy and nanoparticle delivery systems.
• Analysis of nanoparticle characteristics relevant to gene delivery efficiency and toxicity.
• Synthesis of information on targeting tumorigenesis, recurrence, and drug resistance.

Main Results:

• Gene therapy demonstrates high potency and specificity with low off-target toxicity.
• Nanoparticles offer desirable characteristics for gene delivery, including low toxicity and high efficiency.
• Nanoparticles can be engineered for multi-functional applications in cancer gene therapy.

Conclusions:

• Gene therapy is progressing towards becoming a primary cancer treatment modality.
• Nanoparticles represent a key enabling technology for advancing cancer gene therapy.
• Further research into nanoparticle design is crucial for optimizing cancer treatment outcomes.